Allogene Therapeutics Inc (NAS:ALLO)
$ 2.59 -0.18 (-6.5%) Market Cap: 540.75 Mil Enterprise Value: 177.32 Mil PE Ratio: 0 PB Ratio: 0.96 GF Score: 35/100

Allogene Therapeutics Inc (ALLO) Transcripts

  • 1